Lopetuso LR - Search Results

1

Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists.

Nardone OM, Marasco G, Lopetuso LR, Mocci G, Pastorelli L, Petruzzellis C, Scaldaferri F, On Behalf Of The Italian Association Of Young Gastroenterologist And Endoscopist Aggei. Nardone OM, et al. Among authors: lopetuso lr. J Clin Med. 2023 Mar 2;12(5):2005. doi: 10.3390/jcm12052005. J Clin Med. 2023. PMID: 36902792 Free PMC article.

2

Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system.

Kodani T, Rodriguez-Palacios A, Corridoni D, Lopetuso L, Di Martino L, Marks B, Pizarro J, Pizarro T, Chak A, Cominelli F. Kodani T, et al. J Vis Exp. 2013 Oct 16;(80):e50843. doi: 10.3791/50843. J Vis Exp. 2013. PMID: 24193215 Free PMC article.

3

Role of yeasts in healthy and impaired gut microbiota: the gut mycome.

Ianiro G, Bruno G, Lopetuso L, Beghella FB, Laterza L, D'Aversa F, Gigante G, Cammarota G, Gasbarrini A. Ianiro G, et al. Curr Pharm Des. 2014;20(28):4565-9. doi: 10.2174/13816128113196660723. Curr Pharm Des. 2014. PMID: 24180411 Review.

4

Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma.

Ianiro G, Rossi E, Thomas AM, Schinzari G, Masucci L, Quaranta G, Settanni CR, Lopetuso LR, Armanini F, Blanco-Miguez A, Asnicar F, Consolandi C, Iacovelli R, Sanguinetti M, Tortora G, Gasbarrini A, Segata N, Cammarota G. Ianiro G, et al. Among authors: lopetuso lr. Nat Commun. 2020 Aug 28;11(1):4333. doi: 10.1038/s41467-020-18127-y. Nat Commun. 2020. PMID: 32859933 Free PMC article. Clinical Trial.

5

The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide.

Forte E, Pizzoferrato M, Lopetuso L, Scaldaferri F. Forte E, et al. Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):25-37. Eur Rev Med Pharmacol Sci. 2012. PMID: 22338545 Review.

6

The gut barrier: new acquisitions and therapeutic approaches.

Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L, Gasbarrini A. Scaldaferri F, et al. J Clin Gastroenterol. 2012 Oct;46 Suppl:S12-7. doi: 10.1097/MCG.0b013e31826ae849. J Clin Gastroenterol. 2012. PMID: 22955350 Review.

7

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.

Lopetuso LR, Scaldaferri F, Pizarro TT. Lopetuso LR, et al. Fibrogenesis Tissue Repair. 2012 Oct 14;5(1):18. doi: 10.1186/1755-1536-5-18. Fibrogenesis Tissue Repair. 2012. PMID: 23062310 Free PMC article.

8

Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

Scaldaferri F, Petito V, Lopetuso L, Bruno G, Gerardi V, Ianiro G, Sgambato A, Gasbarrini A, Cammarota G. Scaldaferri F, et al. Mediators Inflamm. 2013;2013:391473. doi: 10.1155/2013/391473. Epub 2013 May 8. Mediators Inflamm. 2013. PMID: 23737647 Free PMC article. Review.

9

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

Lopetuso LR, Petito V, Cufino V, Arena V, Stigliano E, Gerardi V, Gaetani E, Poscia A, Amato A, Cammarota G, Papa A, Sgambato A, Gasbarrini A, Scaldaferri F. Lopetuso LR, et al. Dig Liver Dis. 2013 Dec;45(12):1017-21. doi: 10.1016/j.dld.2013.06.007. Epub 2013 Aug 2. Dig Liver Dis. 2013. PMID: 23911613

10

Commensal Clostridia: leading players in the maintenance of gut homeostasis.

Lopetuso LR, Scaldaferri F, Petito V, Gasbarrini A. Lopetuso LR, et al. Gut Pathog. 2013 Aug 13;5(1):23. doi: 10.1186/1757-4749-5-23. Gut Pathog. 2013. PMID: 23941657 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page